Table 1.
Lineages | |||||
Characteristic | Overall. N = 3.435 | No BA.2. N = 2.493 | BA.2. N = 351 | Delta. N = 591 | p -Value2 |
Sex | 0.152 | ||||
Female | 2.029 (59%) | 1.491 (60%) | 210 (60%) | 328 (55%) | |
Male | 1.406 (41%) | 1.002 (40%) | 141 (40%) | 263 (45%) | |
Death for SARS | 86 (2.5%) | 45 (1.8%) | 0 (0%) | 41 (6.9%) | <0.001 |
Age groups | 0.060 | ||||
>60 | 774 (23%) | 530 (21%) | 95 (27%) | 149 (25%) | |
0–29 | 885 (26%) | 657 (26%) | 84 (24%) | 144 (24%) | |
30–60 | 1.776 (52%) | 1.306 (52%) | 172 (49%) | 298 (50%) | |
Age groups | |||||
Characteristic | Overall. N = 3.482 | 0–29. N = 891 | 30–60. N = 1.798 | >60. N = 793 | p -Value 2 |
Sex | <0.001 | ||||
Female | 2.055 (59%) | 525 (59%) | 1.127 (63%) | 403 (51%) | |
Male | 1.427 (41%) | 366 (41%) | 671 (37%) | 390 (49%) | |
Death for SARS | 86 (2.5%) | 1 (0.1%) | 13 (0.7%) | 72 (9.1%) | <0.001 |
n (%); Pearson’s Chi-squared test.